Literature DB >> 21870468

The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder.

Michael Adamaszek1, Sebastian Olbrich, Jürgen Gallinat.   

Abstract

Electroencephalographic (EEG) findings repeatedly reported abnormal synchronous or even epileptiform discharges in panic disorder. Although less frequently occurring in patients with panic disorder, these deviant EEG features during panic attacks were also observed in intracranial EEG. For this purpose, our article reviews the consideration of abnormal synchronous neuronal activity in different neurocircuits, particularly limbic, as a suggested condition of panic attacks. Therapeutic approaches of anticonvulsants have shown reductions of symptoms and frequency of attacks in numerous patients suffering from panic disorder, supporting the presumption of underlying abnormal synchronous neuronal activity. Thus, scalp EEG recordings are still recommended for discovering indications of abnormal synchronous neuronal activity in panic patients.

Entities:  

Mesh:

Year:  2011        PMID: 21870468     DOI: 10.1177/155005941104200305

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  2 in total

1.  Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.

Authors:  Rodrigo Bainy Leal; Mark William Lopes; Douglas Affonso Formolo; Cristiane Ribeiro de Carvalho; Alexandre Ademar Hoeller; Alexandra Latini; Daniel Santos Sousa; Peter Wolf; Rui Daniel Prediger; Zuner Assis Bortolotto; Marcelo Neves Linhares; Kátia Lin; Roger Walz
Journal:  Mol Psychiatry       Date:  2018-06-07       Impact factor: 15.992

2.  The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups.

Authors:  Montserrat Gerez; Enrique Suárez; Carlos Serrano; Lauro Castanedo; Armando Tello
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-18       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.